A group of leading myeloma specialists, known as the International Myeloma Working Group, recently collaborated to develop guidelines for the proper management of anemia with erythropoietin therapy in multiple myeloma patients. The group advised erythropoietin therapy for anemic myeloma patients receiving chemotherapy in order to improve quality of life and to reduce the need for red blood cell transfusions. They further recommended the addition of iron to improve the efficiency of erythropoietin therapy.

Dr. Heinz Ludwig of the Wilhelminen Hospital in Vienna, Austria, presented these guidelines at the International Myeloma Workshop (IMW) …